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Objective. The aim of this study was to examine the effects of
provider profiling on bypass surgery access and outcomes in
elderly patients in New York.
Background. Since 1989, New York (NY) has compiled
provider-specific bypass surgery mortality reports. While some
have proposed that “provider profiling” has led to lower surgical
mortality rates, critics have suggested that such programs lower
in-state procedural access (increasing out-of-state transfers) with-
out improving patient outcomes.
Methods. Using national Medicare data, we examined trends in
the percentages of NY residents aged 65 years or older receiving
out-of-state bypass surgery between 1987 and 1992 (before and
after program initiation). We also examined in-state procedure
use among elderly myocardial infarction patients during this
period. Finally, we compared trends in surgical outcomes in NY
Medicare patients with those for the rest of the nation.
Results. Between 1987 and 1992, the percentage of NY residents
receiving bypass out-of-state actually declined (from 12.5% to
11.3%, p < 0.01 for trend). An elderly patient’s likelihood for
bypass following myocardial infarction in NY increased signifi-
cantly since the program’s initiation. Between 1987 and 1992,
unadjusted 30-day mortality rates following bypass declined by
33% in NY Medicare patients compared with a 19% decline
nationwide (p < 0.001). As a result of this improvement, NY had
the lowest risk-adjusted bypass mortality rate of any state in 1992.
Conclusions. We found no evidence that NY’s provider profiling
limited procedure access in NY’s elderly or increased out-of-state
transfers. Despite an increasing preoperative risk profile, proce-
dural outcomes in NY improved significantly faster than the
national average.
(J Am Coll Cardiol 1998;32:993–9)
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In 1989, the New York (NY) State Department of Health
began collecting detailed clinical data on all coronary artery
bypass surgery cases performed in that state. These data were
then used to develop hospital- and surgeon-specific risk-
adjusted mortality reports (1–6). In 1990, a NY hospital was
suspended from performing bypass surgery, in part because
their observed mortality significantly exceeded the expected
rate. In response to a 1991 lawsuit, NY officials were required
to publicly release surgeon-specific outcomes data under the
Freedom of Information Act (7). Since 1992, the NY State
Department of Health has voluntarily released annual
provider-specific procedure mortality profiles.
The impact of NY’s provider-profiling effort has been
controversial. Hannan et al. (1) have reported that overall
unadjusted and risk-adjusted bypass surgery mortality rates
declined by 21% and 41%, respectively, between 1989 and
1992. They concluded that much of this improvement in
procedural outcomes might be due to NY’s profiling efforts. In
contrast, others suggested that the improved procedural out-
comes in NY resulted from a change in patient selection rather
than an actual improvement in quality of care (8). Surgeons
may have deferred performing bypass on higher-risk patients
either by transferring these patients to hospitals outside NY, or
by directly refusing to offer the procedure in high-risk situa-
tions. Both of these behaviors have been anecdotally reported.
Omoigui et al. (9) noted that patient transfers to the Cleveland
Clinic from NY hospitals rose by 31% between 1989 and 1993.
These NY transfers had generally higher risk profiles than
patients transferred from Ohio or other states. Similarly, a New
York Times reporter detailed how her father was refused open
heart surgery in NY, presumably because of several surgeons’
concern for their own outcomes statistics (10). A third expla-
nation for NY’s declining mortality was that it merely reflected
concurrent national improvements in surgical outcomes. For
example, Ghali et al. (11) recently reported that Massachusetts
experienced declines in bypass surgery mortality similar to
those reported in NY despite not having a statewide profiling
effort.
Our study objectives were to use the national Medicare
database to assess the impact of NY’s provider profiling
program on procedure access and patient outcomes. First, we
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examined whether provider profiling had increased the per-
centage of NY’s elderly residents going out-of-state for bypass
surgery. Second, we investigated whether the use of bypass
surgery following myocardial infarction (MI) had declined in
NY’s elderly since the initiation of provider profiling. Finally,
we examined whether bypass surgery outcomes were improv-
ing more rapidly in NY than in the rest of the nation during
this period.
Methods
Data sources. Our primary data source was the Medicare
claims files provided by the Health Care Financing Adminis-
tration (HCFA). These included the Medicare Provider Anal-
ysis and Review File (used by HCFA between 1987 and 1990)
and the newer Medicare claims format, the National Claims
History Files (used since 1991). Both files contain demographic
and limited clinical and procedural information (ICD-9-CM
codes) on all in-patient hospitalizations that are billed to
Medicare. A patient’s residence was defined by his/her primary
Medicare mailing address. Medicare hospital identifier codes
were also used to define the location of a specific hospital
admission. Mortality data through the first quarter of 1993
came from Medicare records and date-of-death files.
Patient populations. Our overall bypass surgery study pop-
ulation consisted of all Medicare patients age $65 years who
underwent bypass surgery (ICD-9-CM codes 36.10 through
36.19) between 1987 to 1992 in a U.S. hospital. To avoid
counting patients twice, patients undergoing multiple bypass
procedures during the study period were included only once,
defined by the initial procedure. We also excluded Medicare
patients who were under age 65 years, those Medicare benefits
as part of the Railroad Retirement Board or because of
end-stage renal disease.
We also examined trends in the use of bypass surgery
during the initial episode of care (index hospitalization linked
with between-hospital transfers) in higher risk elderly patient
subsets who were admitted to NY hospitals with an acute MI.
Patients were considered to have been admitted for an acute
MI if their principal diagnosis was ICD-9-CM code 410, or, if
they had a secondary diagnosis of MI and a principal diagnosis
of a complication of infarction (such as papillary muscle
rupture). We also examined bypass surgery use in very high
risk MI subgroups including those with advanced age (e.g., 75
to 80 years) and those with other preoperative risk factors such
as congestive heart failure, diabetes mellitus and renal insuf-
ficiency (2,12,13).
Data analysis. We compared demographic and clinical
characteristics for patients undergoing bypass surgery in NY
hospitals during the study period with those receiving proce-
dures in the rest of the nation (U.S. non-NY). We also
examined trends in the yearly number, rate and baseline
characteristics for CABG procedures performed in NY hospi-
tals. The yearly NY CABG rate was calculated by dividing the
number of NY CABG procedures performed per year by the
overall NY Medicare resident enrollee population (available
from Medicare’s 100% Denominator File). Similar baseline
comparisons were also made between NY residents receiving
surgery in a NY hospital (in-state) and those receiving proce-
dures in a hospital outside NY (out-of-state). The frequencies
of coded comorbid diseases (for example, congestive heart
failure or renal disease) were determined using ICD-9-CM
applied to discharge abstract information (14). We also calcu-
lated a composite measure of comorbidity, the Charlson Index,
applied to these ICD-9-CM diagnoses (14–16).
We tested the significance of temporal trends in patient
characteristics and out-of-state procedure rates using simple
linear regression models (for continuous variables) and logistic
regression models (for categorical variables) with year as the
independent variable. Comparisons of trends in bypass surgery
use in NY vs. U.S. non-NY hospital MI patients were made
using regression models which included procedure year, hos-
pital location (NY vs. non-NY) and an interaction term
(hospital location by year) as independent predictors and
tested the significance of the interaction term. Comparison of
temporal trends in unadjusted 30-day mortality rates in NY vs.
U.S. non-NY hospitals was made in a similar fashion.
We used a logistic regression model to calculate the risk-
adjusted yearly decline in the likelihood for 30-day mortality
following bypass surgery for individual states. This model
included preoperative risk factors (patient age, race, gender,
acute MI admission and Charlson comorbidity index), hospital
location (each state), procedure year (continuous variable) and
the interaction terms (state by procedure year). For each state,
the coefficient of (state by year) interaction term, when added
to the coefficient for procedure year and exponentiated, rep-
resents the yearly odds of mortality for the particular state.
This odds ratio was converted to a yearly decline by compari-
son to 1.0 (e.g., an odds ratio of 0.93 implies a decline of 7%).
Finally, risk adjusted mortality rates by state in 1992 were
calculated by using a similar regression model after limiting the
dataset to include 1992 procedures only (and excluding tem-
poral factors). State-specific coefficients from this model (rel-
ative to the comparison state, NY) were then converted to
odds ratios. These odds ratios were then multiplied by the NY
mortality rate for 1992 to get state-specific, risk adjusted 1992
mortality rates. This method uses the NY rate as a standard to
which all other state rates are compared (17).
Results
Baseline characteristics. Baseline characteristics for NY
and U.S. non-NY patients receiving bypass surgery between
1987 and 1992 are displayed in Table 1. While NY bypass
patients were generally similar to those from the rest of the
United States, NY patients were slightly older, more likely to
have diabetes mellitus and congestive heart failure and less
likely to have had an acute MI prior to bypass surgery. Table 2
displays temporal trends in bypass surgery use in NY’s Medi-
care population between 1987 and 1992. The number of bypass
procedures performed rose by 57% during this period, from
5,170 in 1987 to 8,120 in 1992. The yearly bypass rate among
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NY Medicare resident enrollees also rose by 50% between
1987 and 1992; from 2.4 to 3.6 bypass cases per 1,000 enrollees
per year. The mean age of NY’s bypass patients also rose
slightly, including a significantly higher percentage of octoge-
narian patients (p , 0.001 for trend). There was also a rise in
the percentage of bypass surgery cases that were performed
following an acute MI, and in those with multiple comorbid
illnesses (p , 0.001 for trend). In terms of changes in process
measures, there was a significant increase in the use of internal
mammary artery grafts during bypass in NY, from 30% in 1987
to 51% in 1992 (p , 0.001 for trend).
Out-of-state bypass use. Figure 1 displays temporal trends
in the percentage of NY residents receiving bypass surgery
out-of-state. The out-of-state procedure rate prior to provider
profiling (1987 to 1989) ranged between 12.5% and 14.3% per
year. After the program was initiated, NY’s out-of-state bypass
surgery rate declined to its lowest rate (11.3%) in 1992. In fact,
the overall trend for out-of-state bypass surgery use declined
between 1987 and 1992 (p , 0.001 for trend).
Although the overall percentage of out-of-state bypass
surgery referrals declined after provider profiling began, it
remained possible that there was a bias towards referring
higher risk patient out-of-state. Table 3 compares patient
characteristics for NY residents receiving bypass surgery in-
state vs. those referred out-of-state. In contrast with prior
reports (9), NY residents receiving out-of-state surgery had
demographics similar to those receiving in-state surgery.
In-state access to bypass surgery. To address whether
bypass surgery was less accessible to NY’s higher risk elderly
after provider profiling initiation, we examined trends in
bypass surgery use among patients aged 65 to 70 years and 75
to 80 years who were admitted for acute MI (Fig. 2). While NY
MI patients were generally less likely to receive bypass surgery
than those admitted outside NY, the percentage of NY MI
patients receiving surgery rose significantly from 1987 to 1992.
For example, the rate of in-hospital bypass surgery among NY
MI patients aged 65 to 70 rose from 3.4% in 1987 to 8.4% in
1992, paralleling national trends (Fig. 2). We subsequently
repeated this analysis for even higher risk elderly subsets (i.e.,
those with concomitant MI and congestive heart failure,
diabetes mellitus or renal insufficiency). The results in each
case were the same as described for the overall MI group
(demonstrating increased bypass use in NY in these high risk
subgroups over time, paralleling national trends). Thus, we
found no evidence that the initiation of NY’s profiling program
has resulted in a decline in procedural access for NY’s elderly
residents.
Trends in bypass surgery mortality. Figure 3 displays
temporal trends in 30-day unadjusted mortality rates following
bypass surgery for NY and U.S. non-NY Medicare patients.






Mean age (yr) 72.2 (68,75) 71.9 (68,75)
Age .80 yr 9% 8%
Female 34% 34%
Nonwhite 5% 5%
AMI admission 11% 13%
Congestive heart failure 15% 14%
Diabetes mellitus 17% 15%
Peripheral vascular disease 4% 4%
Chronic pulmonary disease 2% 2%
Charlson comorbidity index ($2) 7% 6%
IMA used 41% 38%
Values are means (25th and 75th percentiles). Note: Given large sample
sizes, all p values , 0.01 except Female (p 5 0.61), Nonwhite (p 5 0.03),
Congestive heart failure (p 5 0.07) and Peripheral vascular disease (p 5 0.02).
AMI 5 acute myocardial infarction; IMA 5 internal mammary artery grafts.
Table 2. Trends in NY State’s CABG Population
Variable 1987 1988 1989 1990 1991 1992
NY Medicare CABG patients (n) 5,170 5,682 5,936 6,875 7,613 8,120
CABG rate* 2.4 2.6 2.7 3.1 3.5 3.6
Mean age (yr) 71.6 71.7 72.0 72.2 72.4 72.7
Age .80 yr 7% 6% 8% 9% 10% 11%
Female 33% 34% 34% 33% 35% 35%
Nonwhite 4% 4% 5% 5% 6% 6%
AMI admission 8% 10% 10% 13% 12% 12%
Charlson comorbidity index $2 6% 5% 5% 5% 7% 11%
IMA used 30% 33% 35% 42% 45% 51%
*Per 1,000 NY Medicare resident enrollees per year. For time trends, p , 0.0001 (1987 to 1992) except for % Female
(p 5 0.01). CABG 5 coronary artery bypass graft surgery; other Abbreviations as in Table 1.
Figure 1. Yearly trends in the percentage of NY residents receiving
bypass surgery at hospitals outside NY state between 1987 and 1992.
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While unadjusted mortality rates fell significantly for both
groups between 1987 and 1992, it fell significantly faster in NY
than in the rest of the nation (p 5 0.005 for interaction term,
NY by year). For example, NY’s 30-day mortality rate follow-
ing bypass declined by 33% from 1987 to 1992 (from 6.0% to
4.0%). For U.S. non-NY patients, bypass surgery mortality
declined by 19% (from 6.7% to 5.4%) during this period.
Similarly, for the 4-year period from 1989 to 1992 (when NY’s
provider profiling existed), the corresponding decline in ob-
served bypass mortality in NY vs. the rest of the nation was
22% vs. 9% (p , 0.001).
We also calculated the degree to which NY patients’
average yearly procedural mortality risk declined relative to
the rest of the nation. After adjusting for age, race, gender,
acute MI admission and comorbid illness, a NY patient’s
likelihood for dying within 30 days of bypass surgery declined
an average of 10.3% per year between 1987 and 1992 com-
pared with 5.8% for patients in the rest of the nation.
As a final method of examining the relationship between
provider profiling programs and surgical outcomes, we dis-
played each state’s yearly decline in bypass mortality (from
1987 to 1992) by their ending (1992) procedural mortality rate
(Fig. 4). In Figure 4 the cross-bars represent the national
averages for these two measures, thus creating quadrants. If
NY’s provider profiling program influenced surgical outcomes,
NY’s surgical mortality rate should have declined faster than
the majority of states (right half of the graph) and they should
have one of the lowest ending mortality rates (bottom half of
the graph). As is evident, NY was one of the nation’s most
improved bypass performer’s between 1987 and 1992 and had
Figure 2. Rates of in-hospital bypass surgery following myocardial
infarction among patients aged 65 to 70 years (boxes) and 75 to 80
years (triangles) in NY (solid lines) and U.S. non-NY hospitals
(dotted lines).







Mean age (yr) 72.2 (68,75) 72.1 (68,75)
Age .80 yr 9% 9%
Female 35% 33%
Nonwhite* 5% 3%
AMI admission 11% 11%
Congestive heart failure 15% 15%
Diabetes mellitus* 17% 15%
Peripheral vascular disease 4% 5%
Chronic pulmonary disease 2% 2%
Charlson comorbidity index ($2) 7% 7%
Values are means (25th and 75th percentiles). *p , 0.001. Abbreviations as
in Table 2.
Figure 3. Yearly trends in 30-day mortality rates following bypass
surgery in NY (squares) vs. U.S. non-NY hospitals (diamonds).
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the nation’s lowest surgical mortality rate in 1992. Interest-
ingly, surgical outcomes in northern New England (Maine,
Vermont and New Hampshire), another area which has imple-
mented bypass surgery provider profiling programs, also de-
clined faster than the national average and had lower than
average mortality rates in 1992.
Discussion
Since 1989, the NY State Department of Health has
collected detailed clinical and outcomes data on all patients
undergoing bypass surgery in their state, and has used these
data to report both unadjusted and risk-adjusted bypass sur-
gery mortality rates (1). New York was the first state in the
nation to publicly release these provider profiles as “cardio-
vascular scorecards,” meant to increase consumer awareness
(18). While many have suggested (on the basis of anecdotal
reports) that provider profiling programs may adversely affect
physician practice behaviors, empirical data supporting or
refuting such claims were limited. Using a longitudinally linked
national claims database, we found that since NY has enacted
a profiling initiative, bypass surgery outcomes have improved
markedly without any evidence that access to care has de-
clined.
Effects on physician behavior. Before public release, NY’s
provider-specific mortality data are risk-adjusted for potential
differences in severity of illness using a validated risk-
prediction model (5). State officials maintain that the model
adequately compensates a surgeon for taking on higher-risk
patients and, if anything, overcompensates for the highest-risk
cases (6). Despite this contention, many critics of the program
have asserted that surgeons’ natural reaction to having their
outcomes monitored is to refer or refuse those patients with
higher procedural risk (8,18).
Recently, Omoigui et al. (9) published a single-institution
review supporting the contention that NY surgeons were
transferring their highest risk patients out-of-state. The au-
thors reported that there was an increase in both the number
of patients and their disease severity transferred to the Cleve-
land Clinic from NY for bypass between 1989 and 1993 (n 5
482). In contrast to these single-center results, when using a
national database we found no evidence for a widespread
increase in out-of-state transfers from NY for bypass surgery.
Figure 4. Individual states’ 1992 adjusted bypass surgery 30-day mor-
tality rate (controlling for age, gender, race, acute MI admission and
comorbidity) vs. their adjusted average yearly decline in bypass surgery
mortality risk between 1987 and 1992. The crosslines indicate national
averages. Note: NNE refers to the northern New England region
(Maine, New Hampshire and Vermont) which share a provider
profiling program. LoVol refers to a composite of 10 states performing
500 or less bypass surgeries per year (including Alaska, Wyoming,
Delaware, Idaho, New Mexico, Hawaii, Rhode Island, Montana and
North and South Dakota).
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In our study, out-of-state bypass procedures may have oc-
curred in one of three general situations: patients living near
NY’s state boarder who cross-over to a neighboring state for a
procedure; patients who are away from home when the need
for bypass surgery occurs (e.g., vacation, dual homesite); and
patients who are specifically transferred out-of-state for bypass
surgery. While the “basal rates” for the two former situations
should be relatively constant, if physicians were transferring a
significant number of higher-risk elderly patients out-of-state
for bypass, the overall rate should have increased over time. In
fact, NY elderly residents were actually less likely to have their
procedure performed outside NY after the profiling program
was initiated. Additionally, while claims data provide only
limited information on disease severity, we found no significant
differences in age, gender, rates of acute MI or comorbid
illness burden in NY residents receiving procedures out-of-
state as compared with NY residents receiving in-state surgery.
Given these national observations, it appears likely that the
Cleveland Clinic’s experience was an exception resulting from
particular local care patterns rather than the general rule.
New York’s provider profiling program may also have
affected surgeons’ willingness to operate on higher-risk pa-
tients. While it is difficult to monitor changes in procedure
access, we examined temporal trends in bypass surgery use
among all elderly Medicare enrollees (Table 2) and among
higher-risk elderly MI patients in NY (Fig. 2). Had NY
surgeons become more conservative in their care, we would
have expected to see a decline in bypass surgery use, particu-
larly among these high-risk patients, corresponding to the
initiation of the profiling program. Care patterns in the rest of
the nation during this period served as a control for nonspecific
changes. Consistent with previous studies, we noted that NY
physicians used revascularization procedures less frequently in
post-MI patients than physicians in other regions of the
country (19,20). However, we also found that NY elderly
high-risk MI patients were actually more likely to receive
bypass surgery since the program’s initiation, mirroring na-
tional trends (Fig. 2). Thus, we were unable to detect systemic
evidence for decreased access to bypass surgery in NY’s elderly
since provider profiling began.
Mortality outcomes. The most important measure of any
quality improvement effort is its effect on patient outcomes.
Hannan et al. (1) previously reported that overall unadjusted
and risk-adjusted in-hospital mortality rates in NY have de-
clined significantly between 1989 and 1992. Our study con-
firmed that overall unadjusted bypass mortality rates in NY
Medicare patients declined significantly faster than the rest of
the nation from 1987 to 1992, 33% vs. 19% (p , 0.01 for trend
comparisons). Furthermore, this decline in mortality was most
profound in NY between 1989 to 1992, after the initiation of
the profiling efforts and during a period when national mor-
tality averages declined only slightly (Fig. 3).
We also found that risk-adjusted surgical mortality in NY
improved faster than almost all individual states between 1987
to 1992 (Fig. 4). As a result, NY had the lowest risk-adjusted
mortality rate in the country in 1992. It is also interesting to
note that the other area of the country which initiated a
provider profiling program during similar time periods, north-
ern New England, experienced significantly larger improve-
ments in their surgical outcomes than other areas of the
country (Fig. 4) (21,22).
These results contrast with those recently reported by Ghali
et al. (11). They found that Massachusetts (a state without
provider profiling) experienced significant improvements in
surgical outcomes from 1990 to 1994. While our study con-
firmed that bypass mortality improved in Massachusetts (a
25% decline in unadjusted Medicare procedural mortality
between 1987 to 1992), this decline was significantly less than
that experienced by either NY or northern New England. In
part these differences in study results may be due to differences
in the years of study and patient inclusion criteria (our study
included all bypass surgery cases, but was limited to the elderly,
while theirs included all age patients, but was limited to certain
diagnosis-related groups). Finally, even if bypass outcomes in
Massachusetts improved to a similar degree as in NY and
northern New England, this may represent a “spill-over” of the
effect of the quality improvement programs (from NY and
northern New England to Massachusetts) resulting from its
geographic location directly between two areas with statewide
profiling programs.
If provider profiling has led to improved outcomes, the
mechanism by which this program works remains unclear.
While public disclosure of outcomes scorecards could have
affected patients’ or physicians’ surgical referral decisions, NY
State officials have not found evidence for mass patients
migration from high- to low-mortality hospitals since the public
release of provider profiles (5). Additionally, our study dem-
onstrated that northern New England (which does not publicly
disclose its provider’s outcome rating) achieved similar im-
provements in surgical outcomes to those in NY (21,22).
Alternatively, provider profiling outcomes data may have been
used internally by hospitals and physician to motivate internal,
individualized, quality improvement initiatives. For example,
Chassin et al. (5) have reported that certain NY hospitals
restricted operating privileges for surgeons with poor out-
comes while other institutions have improved their man-
agement of unstable patients. Malenka and O’Connor (22)
similarly reported that outcomes feedback has promoted
provider-initiated quality improvement programs in northern
New England.
Limitations. While Medicare is currently the only data
source available for examining national care trends, these data
are limited in terms of the extent and accuracy of clinical
information provided (23). This limitation prevented us from
comparing fully risk-adjusted outcomes results. It is notable,
however, that baseline characteristics for NY and U.S. non-NY
bypass patients were strikingly similar, making significant
differences in disease severity less likely. New York outcomes
were also consistently better than nationwide outcomes after
adjusting for available risk markers. Our results were limited to
patients aged 65 years or older and may not reflect care
patterns or outcomes in younger patients. However, we would
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have expected that if NY’s profiling efforts had adversely
affected access to care, the higher-risk elderly would have
experienced the largest decline in in-state procedures. Our
results only reflect care through the end of 1992 and NY
surgeons may have altered their practice patterns since then.
Finally, we examined general trends in care and outcomes over
time and cannot rule out isolated incidences of altered clinical
behavior resulting from the profiling effort.
Conclusions. Since the enactment of NY State’s bypass
surgery provider profiling, there has been an increase in the
number and rate of bypass surgery procedures performed in
NY (including a higher percentage of older patients, more
acute MI patients and more comorbidity). We found no
empirical evidence that NY residents were being forced to seek
out-of-state bypass surgery, or that access to procedures had
declined in high-risk elderly NY residents since the program’s
initiation. Furthermore, mortality following bypass surgery has
declined significantly faster in NY as compared with the rest of
the nation. These data support NY’s provider profiling pro-
gram as a potential means of improving patient outcomes while
maintaining access to care.
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